Potential contribution of proteases to neuronal damage

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Calpains are calcium-dependent proteases discovered 30 years ago, with two major isoforms and an endogenous inhibitor, calpastatin.
• Calpain activity is regulated by calcium (Ca2+) and implicated in cellular processes like mitosis, muscle differentiation, and membrane fusion.
• Increased calpain activation is observed in aging, various diseases (muscular dystrophy, Alzheimer's), and acute injuries (TBI, ischemia).

Purpose of the Study:

• To review the discovery, regulation, and implications of calpains in physiological and pathological conditions.
• To discuss the development and therapeutic potential of calpain inhibitors.
• To highlight the advantages of calpain inhibitors in treating conditions involving excitotoxicity and elevated Ca2+.

Main Methods:

• Literature review of calpain research, including inhibitor development.
• Analysis of calpain's role in various cellular functions and disease states.
• Evaluation of therapeutic strategies involving calpain inhibition.

Main Results:

• Calpains play diverse roles, with dysregulation linked to numerous diseases and injuries.
• Various classes of calpain inhibitors have been developed, including peptidyl aldehydes, irreversible inhibitors, and others.
• Calpain inhibitors offer potential therapeutic advantages by targeting a later stage in cell death pathways.

Conclusions:

• Calpain inhibitors represent a promising therapeutic avenue for conditions associated with elevated Ca2+ and excitotoxicity.
• Further research is necessary to fully elucidate the role of calpains and optimize inhibitor strategies.
• The contribution of other proteolytic cascades to neuronal damage, particularly after TBI, requires consideration.